View More View Less
  • 1 Instituto Nazionale per la Ricerca sul Cancro Laboratorio di Farmacologia Tossicologica Viale Benedetto XV 10-16132 Genova (Italy)
  • | 2 Università di Pavia Dipartimento di Chimica Generale Viale Taramelli 12-27100 Pavia (Italy)
Restricted access

Abstract  

Cisplatin (CDDP) is an antineoplastic drug used in the treatment of a wide variety of tumors. This paper describes an investigation carried out on pregnant mice after intragastric or intraperitoneally treatment with CDDP from day 11 to 13 of gestation. Platinum content in different tissues, namely liver, kidney, placenta and brain, was determined at 18 day of pregnancy. Two analytical techniques were used, i.e. neutron activation analysis and atomic absorption spectroscopy. Results of both techniques are presented and discussed in terms of precision, accuracy and sensitivity. Neutron activation analysis appears to provide results better correlated with the drug treatment.